• Find people
• Intranet

News

• 28/09/2010 - Press release

  The Mediterranean diet can help prevent cardiovascular risk in children

  

  For the first time, a study conducted by the Cardiovascular Risk and Nutrition Research Group at IMIM and the Community Nutrition Research Group - Nutrition Research Foundation (FIN) at the Barcelona Science Park (PCB) shows that youth who eat a Mediterranean diet have a smaller waist circumference than those who do not.

  Més informació "The Mediterranean diet can help prevent cardiovascular risk in children"

• 15/09/2010 - Press release

  New therapeutic avenue discovered to fight against leukaemia

  

  A study carried out by researchers from the stem cells and cancer research group of the IMIM (Hospital del Mar Research Institute) has shown that if deactivation of the NFkB protein complex in T cell acute lymphoblastic leukaemia is forced, leukaemia is eliminated. This opens the doors for the development of new drugs for this type of leukaemia.

  Més informació "New therapeutic avenue discovered to fight against leukaemia"

• 10/09/2010 - Press release

  International study shows that "Non-pharmacological Therapies" are just as effective as drugs for Alzheimer's disease.

  

  A worldwide network of 22 scientists, among them Jordi Peña, a researcher at the Research Group in Behavioral Neurology and Dementia at IMIM and neurologist at the Hospital del Mar, has just published a large study that for the first time provides clear evidence on the effectiveness of Non-pharmacological Therapies in Alzheimer’s disease.

  Més informació "International study shows that "Non-pharmacological Therapies" are just as effective as drugs for Alzheimer's disease."

• 08/09/2010 - Press release

  Diabetics in the south of Europe have less cardiovascular diseases than patients who have already had a heart attack

  

  Type 2 diabetes is a heart risk factor, along with other factors such as lipid profile, hypertension and obesity. Some studies put the cardiovascular mortality risk in diabetic patients on a par with that presented by non-diabetics who have had a first myocardial infarction. For the first time ever, it has been shown that this is not the case in the south of Europe.

  Més informació "Diabetics in the south of Europe have less cardiovascular diseases than patients who have already had a heart attack"

• 31/08/2010 - Press release

  genetic risk indicator has been developed that is associated with the probability of ischaemic heart disease

  

  A study led by IMIM researchers in Barcelona has developed a genetic risk indicator that has a linear association with the probability of ischaemic heart disease. This risk indicator is independent of classic cardiovascular risk factors already known and may provide information that is supplementary to them.

  Més informació "genetic risk indicator has been developed that is associated with the probability of ischaemic heart disease"

• 10 august 2010 - Press release

  Cigarette smoke contributes to muscle dysfunction

  

  This is the first study in which proteins involved in metabolism and muscle contraction are shown to have higher levels of oxidation as a result of tobacco smoke, which could cause alterations in the structure and function of muscle fibres.

  Més informació "Cigarette smoke contributes to muscle dysfunction"

• 4th august 2010 - Press release

  59 new genetic variants associated with blood cholesterol and triglyceride levels have been identified

  An international study which will be published in the next issue of the prestigious journal Nature, in which researchers from the IMIM have participated, has identified 95 genetic variants related to LDL cholesterol, HDL cholesterol and triglyceride levels. Of these 95 associated genetic variants, 59 had not been previously identified.

  Més informació "59 new genetic variants associated with blood cholesterol and triglyceride levels have been identified"

• 1 august 2010 - Press release

  A new antibody-producing molecular mechanism has been identified which could be key to lupus or rheumatoid arthritis

  An international team, led by the IMIM (Hospital del Mar Research Institute) and the Mount Sinai School of Medicine in New York, has identified a new molecular mechanism for the production of antibodies by B-lymphocytes. This finding opens the door to new treatments for autoimmune diseases, such as lupus and rheumatoid arthritis, and perhaps tumors of the immune system such as lymphoma and multiple myeloma.

  Més informació "A new antibody-producing molecular mechanism has been identified which could be key to lupus or rheumatoid arthritis"

• 22 july 2010 - Press release

  Rare genetic variants also contribute to the appearance of complex diseases

  An international study, in which researchers from the IMIM (Hospital del Mar Research Institute) have participated as the only Spanish researchers, has shown that rare genetic variants, which are present in less than 1% of the population, also contribute to determining individual susceptibility to suffer from complex diseases such as hypertriglyceridemia (high levels of triglycerides).

  Més informació "Rare genetic variants also contribute to the appearance of complex diseases"

• 12/07/2010 - General information

  20th European Athletics Championships

  The City of Barcelona will host from 27 July to 1 August 2010 the 20th European Athletics Championships, Barcelona 2010. The Hospital del Mar will be one of the reference hospitals for both its timetabled care (tests) as well as emergency services and the IMIM's Anti-Doping Control Laboratory will be in charge of performing the doping control tests for the championships

  Més informació "20th European Athletics Championships"